Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 20 min ago
PreprintCC BY-NC-NDmedRxiv

Mortality and Epidemiological Characteristics of Pulmonary Embolism in Spain (2022-2024)

  1. 1Hospital Universitario Severo Ochoa (Madrid, Spain)

Abstract

BackgroundAcute pulmonary embolism (PE) is a major cause of cardiovascular morbidity and mortality. This study aims to describe the epidemiological trends, clinical complexity, and in-hospital mortality of PE admissions in Spain from 2022 to 2024.

MethodsWe conducted a nationwide, retrospective study using the Spanish Minimum Basic Data Set for Hospitalization (MBDS-H) for adult patients admitted with acute PE.

ResultsWe identified 125,305 hospital admissions for acute PE. The median patient age was 74 years with a slight male predominance (51-52%). A high comorbidity burden was observed: 61-62% had COPD, 35-37% hypertension, and 21-24% malignancy; ICU admissions increased from 11% to 13% (p < 0.001), with median ICU stay rising from 4 to 7 days (p < 0.001). In-hospital mortality significantly decreased during 2022-2024 from 13.12% to 11.44% (p = 0.013). Mortality per 100,000 inhabitants was consistently higher in men.

ConclusionThis study highlights the high healthcare burden posed by acute embolism in hospitals, demonstrating an increase in patient complexity alongside a decline in overall mortality.

Related

  1. Sex-Based Differences in Clinical Characteristics and Outcomes in Patients with Acute Pulmonary Embolism. An Analysis of 1000 Pulmonary Embolism Response Team Activations
    Maria Obeidat, Dana Marsy, Erin Vandyke +8
    Women's Health ReportsPeer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
  2. Development and Validation of a Predictive Model for 6-Month All-Cause Mortality in Pulmonary Embolism.
    Zhiye Wu, Xuemei Wu, Xinhuang Hou +3
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Long-Term Outcomes of Mortality and CTEPH in Patients With Massive/Submassive Pulmonary Embolism Treated With Thrombolytics: Retro-Prospective Analysis
    Esra Oğuz, Ali Nihat Annakkaya MD
    Clinical and Applied Thrombosis/HemostasisPeer-reviewedCC BYFull textCardiovascular medicineDOAJ
  4. Pulmonary Embolism‐Attributable Mortality in Patients With Atherosclerotic Cardiovascular Disease in the United States from 2010 to 2023
    Marco Zuin, Claudio Bilato, Gianluca Rigatelli +2
    Journal of the American Heart AssociationPeer-reviewedCC BY-NC-NDCardiovascular medicineCrossref
  5. Prognostic value of the C-reactive protein–albumin–lymphocyte index for predicting one-year mortality in acute pulmonary embolism
    Abdulkadir Kara, Güney Erdoğan, Serkan Sivri +6
    Frontiers in Cardiovascular MedicinePeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
BibTeX
@misc{mendopedrajas2026mortality,
  title = {{Mortality and Epidemiological Characteristics of Pulmonary Embolism in Spain (2022-2024)}},
  author = {I. Mendo-Pedrajas and P. Rondon-Fernandez and C. de-Juan-Alvarez and S. Coronado-Fernandez and R. Garcia-Carretero},
  howpublished = {medRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.03.26362157},
  url = {https://www.medrxiv.org/content/10.64898/2026.09.03.26362157v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Mortality and Epidemiological Characteristics of Pulmonary Embolism in Spain (2022-2024)
AU  - I. Mendo-Pedrajas
AU  - P. Rondon-Fernandez
AU  - C. de-Juan-Alvarez
AU  - S. Coronado-Fernandez
AU  - R. Garcia-Carretero
PY  - 2026
DA  - 2026/09/03
PB  - medRxiv
DO  - 10.64898/2026.09.03.26362157
UR  - https://www.medrxiv.org/content/10.64898/2026.09.03.26362157v1
AB  - BackgroundAcute pulmonary embolism (PE) is a major cause of cardiovascular morbidity and mortality. This study aims to describe the epidemiological trends, clinical complexity, and in-hospital mortality of PE admissions in Spain from 2022 to 2024.  MethodsWe conducted a nationwide, retrospective study using the Spanish Minimum Basic Data Set for Hospitalization (MBDS-H) for adult patients admitted with acute PE.  ResultsWe identified 125,305 hospital admissions for acute PE. The median patient age was 74 years with a slight male predominance (51-52%). A high comorbidity burden was observed: 61-62% had COPD, 35-37% hypertension, and 21-24% malignancy; ICU admissions increased from 11% to 13% (p < 0.001), with median ICU stay rising from 4 to 7 days (p < 0.001). In-hospital mortality significantly decreased during 2022-2024 from 13.12% to 11.44% (p = 0.013). Mortality per 100,000 inhabitants was consistently higher in men.  ConclusionThis study highlights the high healthcare burden posed by acute embolism in hospitals, demonstrating an increase in patient complexity alongside a decline in overall mortality.
ER  -